Published date: 17 June 2020

Last edited date: 17 June 2020

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 1 April 2020

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£3,150,000

Procurement reference

tender_234496/862091

Published date

17 June 2020

Closing date

1 April 2020

Contract start date

22 April 2020

Contract end date

31 July 2020

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

A requirement to secure hydroxychloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.

More information

Attachments

Award information

Awarded date

22 April 2020

Contract start date

22 April 2020

Contract end date

31 July 2020

Total value of contract

£3,150,000

This contract was awarded to 1 supplier.

HFA Healthcare Products Ltd

Address

Studios 13,15,22, & 24 Birmingham West Midlands B3 1QS

Reference

Companies House number: 09208084

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Telephone

0

Email

lynne.nichols@dhsc.gov.uk